Vestal Point Capital, LP - 31 Mar 2025 SCHEDULE 13G Report for Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share (TYRA)

Filing Manager
Vestal Point Capital, LP
Reporting Manager
Vestal Point Capital, LP
Security
Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share
Symbol
TYRA
Shares outstanding
53,330,167 shares
Disclosed Ownership
2,879,829 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 16:14:46 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vestal Point Capital, LP 5.4% 2,879,829 0 2,879,829 /s/ Ryan Wilder By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder 5.4% 2,879,829 0 2,879,829 /s/ Ryan Wilder Ryan Wilder, Individually